Bioinformatics Scientist: TF Discovery in Reprogramming

e184; Portland (OR); On-site; USD 85,000 - 120,000; Full time

Benefits offered by this job

Competitive salary + equity participation

Comprehensive Medical, Dental, Vision, and 401(k) with company match

20 days PTO + 11 paid holidays

Job summary

e184 is looking for a Bioinformatics Scientist to lead computational analyses in multi-modal genomics, focusing on gene regulatory networks and cellular reprogramming. Ideal candidates will have a PhD in Bioinformatics or Computational Biology and strong expertise in RNA-seq analysis. This role involves close collaboration with experimental teams to translate computational predictions into experimental designs, making significant contributions to advancements in human fertility and reproductive medicine.

Qualifications

• Demonstrated track record applying computational TF ranking to cellular reprogramming.
• Hands-on experience with established GRN inference methods.
• Strong publication record in related fields.

Responsibilities

• Lead end-to-end TF discovery for cellular reprogramming.
• Analyze multi-modal genomics data to identify transcription factors.
• Collaborate closely with wet lab teams on experimental designs.

Skills

Computational TF ranking

GRN inference

Multi-platform RNA-seq expertise

Programming in Python and R

Statistical analysis for high-dimensional data

Education

PhD in Bioinformatics, Computational Biology, or related field

Tools

Scanpy

Seurat

Cloud platforms

Job description

e184 is looking for a Bioinformatics Scientist to lead computational analyses in multi-modal genomics, focusing on gene regulatory networks and cellular reprogramming. Ideal candidates will have a PhD in Bioinformatics or Computational Biology and strong expertise in RNA-seq analysis. This role involves close collaboration with experimental teams to translate computational predictions into experimental designs, making significant contributions to advancements in human fertility and reproductive medicine.